Logo image of SATS

ECHOSTAR CORP-A (SATS) Stock Fundamental Analysis

NASDAQ:SATS - Nasdaq - US2787681061 - Common Stock

27.52  -0.22 (-0.79%)

After market: 27.52 0 (0%)

Fundamental Rating

1

Overall SATS gets a fundamental rating of 1 out of 10. We evaluated SATS against 92 industry peers in the Media industry. SATS has a bad profitability rating. Also its financial health evaluation is rather negative. SATS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SATS had negative earnings in the past year.
In the past year SATS had a positive cash flow from operations.
In multiple years SATS reported negative net income over the last 5 years.
SATS had a positive operating cash flow in each of the past 5 years.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B

1.2 Ratios

SATS has a Return On Assets (-3.82%) which is in line with its industry peers.
SATS has a Return On Equity of -11.32%. This is comparable to the rest of the industry: SATS outperforms 40.23% of its industry peers.
SATS has a worse Return On Invested Capital (0.21%) than 71.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SATS is below the industry average of 6.90%.
Industry RankSector Rank
ROA -3.82%
ROE -11.32%
ROIC 0.21%
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

SATS has a Operating Margin of 0.52%. This is in the lower half of the industry: SATS underperforms 70.11% of its industry peers.
In the last couple of years the Operating Margin of SATS has declined.
SATS's Gross Margin of 26.87% is on the low side compared to the rest of the industry. SATS is outperformed by 72.41% of its industry peers.
In the last couple of years the Gross Margin of SATS has declined.
Industry RankSector Rank
OM 0.52%
PM (TTM) N/A
GM 26.87%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

SATS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SATS has more shares outstanding
Compared to 5 years ago, SATS has more shares outstanding
Compared to 1 year ago, SATS has a worse debt to assets ratio.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that SATS is in the distress zone and has some risk of bankruptcy.
SATS has a Altman-Z score (0.83) which is in line with its industry peers.
SATS has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.11, SATS is in line with its industry, outperforming 40.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.02
WACC8.67%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.67 indicates that SATS may have some problems paying its short term obligations.
SATS has a worse Current ratio (0.67) than 86.21% of its industry peers.
SATS has a Quick Ratio of 0.67. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SATS (0.61) is worse than 88.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.61
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SATS have decreased strongly by -280.85% in the last year.
The Revenue has grown by 1426.74% in the past year. This is a very strong growth!
The Revenue has been growing by 57.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-280.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)1426.74%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%841.96%

3.2 Future

Based on estimates for the next years, SATS will show a very negative growth in Earnings Per Share. The EPS will decrease by -150.76% on average per year.
The Revenue is expected to decrease by -9.99% on average over the next years.
EPS Next Y-3488.07%
EPS Next 2Y-605.34%
EPS Next 3Y-388.29%
EPS Next 5Y-150.76%
Revenue Next Year-0.73%
Revenue Next 2Y-2.59%
Revenue Next 3Y-4.14%
Revenue Next 5Y-9.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SATS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SATS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

SATS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.65
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as SATS's earnings are expected to decrease with -388.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-605.34%
EPS Next 3Y-388.29%

More info and screens

0

5. Dividend

5.1 Amount

SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECHOSTAR CORP-A

NASDAQ:SATS (1/22/2025, 4:35:05 PM)

After market: 27.52 0 (0%)

27.52

-0.22 (-0.79%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners83.92%
Inst Owner Change-0.01%
Ins Owners12.19%
Ins Owner Change0.69%
Market Cap7.48B
Analysts73.85
Price Target24.31 (-11.66%)
Short Float %13.09%
Short Ratio9.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-113.27%
Min EPS beat(2)-197.05%
Max EPS beat(2)-29.49%
EPS beat(4)0
Avg EPS beat(4)-265.47%
Min EPS beat(4)-752.94%
Max EPS beat(4)-29.49%
EPS beat(8)4
Avg EPS beat(8)-83.89%
EPS beat(12)5
Avg EPS beat(12)-59.19%
EPS beat(16)9
Avg EPS beat(16)126.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.55%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)-2.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.85%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)4.78%
Revenue beat(8)2
Avg Revenue beat(8)-2.87%
Revenue beat(12)4
Avg Revenue beat(12)-1.96%
Revenue beat(16)8
Avg Revenue beat(16)-1.2%
PT rev (1m)5.46%
PT rev (3m)13.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.71%
EPS NY rev (1m)0%
EPS NY rev (3m)18.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.12%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF 2.24
P/B 0.38
P/tB 0.39
EV/EBITDA 10.65
EPS(TTM)-2.55
EYN/A
EPS(NY)-2.49
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)12.28
OCFY44.63%
SpS101.41
BVpS71.52
TBVpS71.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.82%
ROE -11.32%
ROCE 0.29%
ROIC 0.21%
ROICexc 0.21%
ROICexgc 0.21%
OM 0.52%
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)0.36%
ROA(5y)-0.07%
ROE(3y)-0.44%
ROE(5y)-0.84%
ROIC(3y)1.94%
ROIC(5y)1.61%
ROICexc(3y)2.63%
ROICexc(5y)2.35%
ROICexgc(3y)3.09%
ROICexgc(5y)2.8%
ROCE(3y)2.72%
ROCE(5y)2.26%
ROICexcg growth 3Y-39.21%
ROICexcg growth 5Y-18.25%
ROICexc growth 3Y-34.39%
ROICexc growth 5Y-15.93%
OM growth 3Y-22.28%
OM growth 5Y-13.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.06%
GM growth 5Y-12.47%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA 7.43
Cap/Depr 147.83%
Cap/Sales 14.78%
Interest Coverage 0.06
Cash Conversion 115.1%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.61
Altman-Z 0.83
F-Score3
WACC8.67%
ROIC/WACC0.02
Cap/Depr(3y)122.18%
Cap/Depr(5y)106.75%
Cap/Sales(3y)19.82%
Cap/Sales(5y)21.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-280.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y-3488.07%
EPS Next 2Y-605.34%
EPS Next 3Y-388.29%
EPS Next 5Y-150.76%
Revenue 1Y (TTM)1426.74%
Revenue growth 3Y108.11%
Revenue growth 5Y57.38%
Sales Q2Q%841.96%
Revenue Next Year-0.73%
Revenue Next 2Y-2.59%
Revenue Next 3Y-4.14%
Revenue Next 5Y-9.99%
EBIT growth 1Y-3.64%
EBIT growth 3Y61.74%
EBIT growth 5Y36.68%
EBIT Next Year230.78%
EBIT Next 3Y42.41%
EBIT Next 5Y17.09%
FCF growth 1Y-494.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y509.71%
OCF growth 3Y65.73%
OCF growth 5Y27.06%